Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Recruiting now · Not applicable
Conditions studied: Glioma, Glioblastoma, Metastatic Malignant Neoplasm in the Brain
In brief
This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new strategies to better diagnose, monitor, and treat brain tumors.
Key facts
- Study ID
- NCT04047264
- Run by
- Mayo Clinic
- People needed
- 100
- Starts
- 2020-01-01
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-02-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age >= 18 years
- Diagnosis of the following, based on clinical and radiographic evidence:
- Any glioma
- Metastatic brain tumor of any primary origin
- Epileptic focus requiring surgical resection
- Planned neurosurgical procedure for purposes of biopsy or resection of suspected or previously diagnosed brain tumor (primary or metastatic) or epileptic focus as part of routine clinical care
- Willing to undergo neurosurgical resection or biopsy at Mayo Clinic (Rochester, Minnesota [MN])
- Ability to understand and the willingness to sign a written informed consent document
You may not qualify if…
- Vulnerable populations: pregnant women, prisoners or the mentally handicapped
- Patients who are not appropriate candidates for surgery due to current or past medical history or uncontrolled concurrent illness
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.